Annual EBITDA
$2.69B$1.61B-37.47%
Summary
- Current Value
- As of today, HUM annual EBITDA is $2.69B, down -37.47% on
- Historical Performance
- HUM annual EBITDA is down -33.88% over the past 3 years, and down -33.29% over the past 5 years
- All-Time High Comparison
- HUM annual EBITDA is currently -48.45% below its historical high of $5.22B set on
- 3-Year Low Comparison
- HUM annual EBITDA is at its 3-year low
- Sector Comparison
- HUM annual EBITDA is higher than 96.53% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.69B | -37.5% | -33.9% | -33.3% | +45.2% | |
| Quarterly EBITDA | $338.00M | -62.2% | -77.6% | -82.4% | -50.8% | |
| TTM EBITDA | $2.57B | -13.0% | -41.5% | -58.8% | +14.9% | |
| Price | $264.48 | +4.7% | -48.4% | -35.5% | +383.2% | |
| PE Ratio | 24.79 | -2.3% | +6.7% | +52.8% | +193.4% | |
| Annual Revenue | $117.81B | +10.7% | +40.8% | +81.4% | +280.5% | |
| Annual EPS | $9.99 | -50.1% | -55.9% | -50.3% | +62.4% | |
| Annual EBIT | $1.72B | -49.1% | -48.7% | -50.2% | +7.4% | |
| Annual Net Income | $1.21B | -51.1% | -58.6% | -55.1% | +16.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $4.41B | N/A | -39.1% |
| 5Y | $5.22B | N/A | -48.5% |
| All | $5.22B | -48.5% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.69B | at low | |
| 5Y | $2.69B | at low | |
| All | -$280.00M | +1060.4% |
EBITDA History
FAQ
What is the current annual EBITDA of HUM?
As of today, HUM annual EBITDA is $2.69B
What is 1-year change in HUM annual EBITDA?
HUM annual EBITDA is down -37.47% year-over-year
What is 3-year change in HUM annual EBITDA?
HUM annual EBITDA is down -33.88% over the past 3 years
How far is HUM annual EBITDA from its all-time high?
HUM annual EBITDA is currently -48.45% below its historical high of $5.22B set on December 31, 2020
How does HUM annual EBITDA rank versus sector peers?
HUM annual EBITDA is higher than 96.53% of companies in Healthcare sector
When is HUM next annual earnings release?
The next annual earnings release for HUM is on
Quarterly EBITDA
$338.00M$614.00M-64.50%
Summary
- Current Value
- As of today, HUM quarterly EBITDA is $338.00M, down -64.50% on
- Historical Performance
- HUM quarterly EBITDA is down -62.19% year-over-year, and down -77.63% over the past 3 years
- All-Time High Comparison
- HUM quarterly EBITDA is currently -87.65% below its historical high of $2.74B set on
- 3-Year Low Comparison
- HUM quarterly EBITDA is +154.34% above its 3-year low of -$622.00M reached on
- Sector Comparison
- HUM quarterly EBITDA is higher than 93.85% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $338.00M | -64.5% | -62.2% | -77.6% | -82.4% | |
| Annual EBITDA | $2.69B | – | -37.5% | -33.9% | -33.3% | |
| TTM EBITDA | $2.57B | -17.8% | -13.0% | -41.5% | -58.8% | |
| Price | $264.48 | +3.1% | +4.7% | -48.4% | -35.5% | |
| PE Ratio | 24.79 | +3.1% | -2.3% | +6.7% | +52.8% | |
| Quarterly Revenue | $32.65B | +0.8% | +11.1% | +43.2% | +62.6% | |
| Quarterly EPS | $1.62 | -64.2% | -59.4% | -82.8% | -84.0% | |
| Quarterly EBIT | $134.00M | -81.9% | -79.4% | -89.7% | -92.4% | |
| Quarterly Net Income | $194.00M | -64.3% | -59.6% | -83.7% | -85.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.91B | -82.3% | |
| 3Y | $1.91B | -82.3% | |
| 5Y | $1.91B | -82.3% | |
| All | $2.74B | -87.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$622.00M | N/A | +154.3% |
| 3Y | -$622.00M | +154.3% | |
| 5Y | -$622.00M | +154.3% | |
| All | -$622.00M | +154.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of HUM?
As of today, HUM quarterly EBITDA is $338.00M
What is HUM quarterly EBITDA most recent change?
HUM quarterly EBITDA was down -64.50% on September 30, 2025
What is 1-year change in HUM quarterly EBITDA?
HUM quarterly EBITDA is down -62.19% year-over-year
How far is HUM quarterly EBITDA from its all-time high?
HUM quarterly EBITDA is currently -87.65% below its historical high of $2.74B set on June 30, 2020
How does HUM quarterly EBITDA rank versus sector peers?
HUM quarterly EBITDA is higher than 93.85% of companies in Healthcare sector
When is HUM next earnings release?
The next earnings release for HUM is on
TTM EBITDA
$2.57B$556.00M-17.76%
Summary
- Current Value
- As of today, HUM TTM EBITDA is $2.57B, down -17.76% on
- Historical Performance
- HUM TTM EBITDA is down -12.98% year-over-year, and down -41.51% over the past 3 years
- All-Time High Comparison
- HUM TTM EBITDA is currently -58.80% below its historical high of $6.25B set on
- 3-Year Low Comparison
- HUM TTM EBITDA is at its 3-year low
- Sector Comparison
- HUM TTM EBITDA is higher than 96.02% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.57B | -17.8% | -13.0% | -41.5% | -58.8% | |
| Annual EBITDA | $2.69B | – | -37.5% | -33.9% | -33.3% | |
| Quarterly EBITDA | $338.00M | -64.5% | -62.2% | -77.6% | -82.4% | |
| Price | $264.48 | +3.1% | +4.7% | -48.4% | -35.5% | |
| PE Ratio | 24.79 | +3.1% | -2.3% | +6.7% | +52.8% | |
| TTM Revenue | $126.36B | +2.6% | +9.9% | +38.2% | +69.8% | |
| TTM EPS | $10.67 | -18.1% | -5.5% | -51.6% | -65.8% | |
| TTM EBIT | $1.70B | -23.3% | -14.5% | -52.4% | -69.8% | |
| TTM Net Income | $1.30B | -18.1% | -4.5% | -53.8% | -68.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.34B | -22.9% | |
| 3Y | $4.98B | -48.3% | |
| 5Y | $5.56B | -53.7% | |
| All | $6.25B | -58.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.57B | at low | |
| 3Y | $2.57B | at low | |
| 5Y | $2.57B | at low | |
| All | $53.00M | +4756.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of HUM?
As of today, HUM TTM EBITDA is $2.57B
What is HUM TTM EBITDA most recent change?
HUM TTM EBITDA was down -17.76% on September 30, 2025
What is 1-year change in HUM TTM EBITDA?
HUM TTM EBITDA is down -12.98% year-over-year
How far is HUM TTM EBITDA from its all-time high?
HUM TTM EBITDA is currently -58.80% below its historical high of $6.25B set on September 30, 2020
How does HUM TTM EBITDA rank versus sector peers?
HUM TTM EBITDA is higher than 96.02% of companies in Healthcare sector
When is HUM next earnings release?
The next earnings release for HUM is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- HUM Official Website www.humana.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/49071/000004907125000057/0000049071-25-000057-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/49071/000004907125000007/0000049071-25-000007-index.htm
- HUM Profile on Yahoo Finance finance.yahoo.com/quote/HUM
- HUM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hum